BMS 813160 – 5 mg

Brand:
Cayman
CAS:
1286279-29-5
Storage:
-20
UN-No:
Non-Hazardous - /

BMS 813160 is a dual antagonist of chemokine receptor 2 (CCR2) and CCR5 (IC50s = 6.2 and 3.6 nM, respectively, in radioligand binding assays).{46418,46419} It inhibits chemotaxis induced by the CCR2 ligand MCP-1 in THP-1 cells the CCR5 ligand MIP-1β in isolated peripheral T cells with IC50 values of 0.8 and 1.1 nM, respectively.{46418} BMS 813160 inhibits peritoneal monocyte and macrophage infiltration in an hCCR-2 KI mouse model of thioglycolate-induced peritonitis, with 54% inhibition when administered at a dose of 50 mg/kg twice per day.  

 

Available on backorder

SKU: 28421 - 5 mg Category:

Description

A dual antagonist of CCR2 and CCR5 (IC50s = 6.2 and 3.6 nM, respectively, in radioligand binding assays); inhibits chemotaxis induced by the CCR2 ligand MCP-1 in THP-1 cells the CCR5 ligand MIP-1β in isolated peripheral T cells (IC50s = 0.8 and 1.1 nM, respectively); dose-dependently inhibits peritoneal monocyte and macrophage infiltration in an hCCR-2 KI mouse model of thioglycolate-induced peritonitis, with 54% inhibition at 50 mg/kg twice per day


Formal name: N-[(1R,2S,5R)-5-[(1,1-dimethylethyl)amino]-2-[(3S)-3-[[7-(1,1-dimethylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]amino]-2-oxo-1-pyrrolidinyl]cyclohexyl]-acetamide

Synonyms: 

Molecular weight: 484.6

CAS: 1286279-29-5

Purity: ≥98%

Formulation: A crystalline solid